SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-23-008471
Filing Date
2023-03-16
Accepted
2023-03-16 16:14:35
Documents
5
Effectiveness Date
2023-03-16

Document Format Files

Seq Description Document Type Size
1 S-8 glue-s8-2023.htm S-8 127503
2 EX-5.1 glue-ex5_1.htm EX-5 16083
3 EX-23.1 glue-ex23_1.htm EX-23 3248
4 EX-FILING FEES glue-exfiling_fees.htm EX-FILING FEES 37335
5 GRAPHIC img200495983_0.jpg GRAPHIC 26389
  Complete submission text file 0000950170-23-008471.txt   221692
Mailing Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210
Business Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210 617-949-2643
Monte Rosa Therapeutics, Inc. (Filer) CIK: 0001826457 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270607 | Film No.: 23738962
SIC: 2836 Biological Products, (No Diagnostic Substances)